<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Medical Scientific Bulletin of Central Chernozemye (Naučno-medicinskij vestnik Centralʹnogo Černozemʹâ)</journal-id><journal-title-group><journal-title>Medical Scientific Bulletin of Central Chernozemye (Naučno-medicinskij vestnik Centralʹnogo Černozemʹâ)</journal-title></journal-title-group><issn publication-format="electronic">1990-472X</issn><publisher><publisher-name>Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный медицинский университет имени Н.Н. Бурденко" Министерства здравоохранения Российской Федерации</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">4951</article-id><article-id pub-id-type="doi">10.18499/1990-472X-2016-0-66-89-95</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>DRUG-FREE MODALITIES AND PREVENTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH CONCOMITANT PATHOLOGY - THE ROLE OF PULMONARY REHABILITATION</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Kozhevnikova</surname><given-names>S A</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Budnevskiy</surname><given-names>A V</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Burlachuk</surname><given-names>V T</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ovsyannikov</surname><given-names>E S</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Goncharenko</surname><given-names>O V</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">Voronezh State Medical University</aff><pub-date date-type="epub" iso-8601-date="2016-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2016</year></pub-date><issue>66</issue><fpage>89</fpage><lpage>95</lpage><history><pub-date date-type="received" iso-8601-date="2020-04-25"><day>25</day><month>04</month><year>2020</year></pub-date></history><permissions><copyright-statement>Copyright © 2016, Научно-медицинский вестник Центрального Черноземья</copyright-statement><copyright-year>2016</copyright-year></permissions><abstract>60 people with chronic obstructive pulmonary disease (COPD) of moderate severity and ischemic heart disease were examined, 2 groups are created: 1 group - 30 people who along with medication of diseases passed the program of pulmonary rehabilitation (PPR) - group training, a course of physical exercises; 2 group - 30 people received only medication. As a result of application of PLR for 1 group patients in 12 months positive dynamics of the researched indicators were reliable in comparison with 2 group patients. Thus, it is reasonable to use PLR developed taking into account of concomitant pathology as drug-free modalities and prevention of COPD to increase deliver medical care quality, improvement of clinical-and-psychological status and quality of patient’s life.</abstract><kwd-group xml:lang="ru"><kwd>хроническая обструктивная болезнь легких</kwd><kwd>ишемическая болезнь сердца</kwd><kwd>легочная реабилитация</kwd><kwd>обучение</kwd><kwd>физические упражнения</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Глобальная стратегия диагностики, лечения и профилактики хронической обструктивной болезни легких = Global Initiative for Chronic Obstructive Lung Disease (GOLD, пересмотр 2016) Available at: http://www.goldcopd.org.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Кириллов А.М. Пациенты с сочетанием ишемической болезни сердца и хронической обструктивной болезни легких: клинические проявления и характерные изменения показателей функциональных методов исследования / А.М. Кириллов // Современные проблемы науки и образования. - 2015. - № 4. - С. 15-23.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Татарский А.Р. Ишемическая болезнь сердца. Хроническая обструктивная болезнь легких. Сердечная недостаточность и дыхательная недостаточность: дифференциальная диагностика, лечение / А.Р. Татарский, Д.А. Кириллова // Фарматека. - 2014. - № 13. - С. 63-71.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Федеральные клинические рекомендации по диагностике и лечению хронической обструктивной болезни легких / А.Г. Чучалин и др. - 2014. Available at: http://www.pulmonology.ru/publications/guide.php?clear_cache=Y.</mixed-citation></ref></ref-list></back></article>
